1 |
Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis, a new syndrome. Am J Med 1962;33: 811-28
DOI
|
2 |
Barbour GL, Day JO. Asymptomatic Bartter's syndrome. South Med J 1978;71:1341-4
DOI
ScienceOn
|
3 |
Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nüsing RM, Seyberth HW, et al. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 2002;62:253-60
DOI
ScienceOn
|
4 |
Mourani CC, Sanjad SA, Akatcherian CY. Bartter syndrome in a neonate: early treatment with indomethacin. Pediatr Nephrol 2000;14:143-5
DOI
|
5 |
Littlewood JM, Lee MR, Meadow SR. Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors. Arch Dis Child 1978;53:43-8
DOI
ScienceOn
|
6 |
Proesmans W, Massa G, Vanderschueren-Lodeweyckx M. Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome. Pediatr Nephrol 1988;2:205-9
DOI
|
7 |
Komhoff M, Tekesin I, Peters M, Leonhard A, Seyberth HW. Perinatal management of a preterm neonate affected by hyperprostaglandin E2 syndrome(HPS). Acta Paediatr 2005; 94:1690-3
DOI
ScienceOn
|
8 |
Lee KY, Cho BS, Lee HY, Bernstein J. A case of Bartter's syndrome. J Korean Pediatr Soc 1991;34:849-56
|
9 |
Goodman AD, Vagnucci AH, Hartroft PM. Pathogenesis of Bartter's syndrome. N Engl J Med 1969;281:1435-9
DOI
ScienceOn
|
10 |
Seidel C, Reinalter S, Seyberth HW, Scharer K. Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol 1995;9:723-8
DOI
|
11 |
Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the channel ROMK. Nat Genet 1996;14:152-6
DOI
ScienceOn
|
12 |
Dane B, Yayla M, Dane C, Cetin A. Prenatal diagnosis of Bartter syndrome with biochemical examination of amniotic fluid: case report. Fetal Diagn Ther 2007;22:206-8
DOI
ScienceOn
|
13 |
Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997;17:171-8
DOI
ScienceOn
|
14 |
Komhoff M, Jeck ND, Seyberth HW, Grone HJ, Nusing RM, Brever MD. Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter- like syndrome. Kidney Int 2000;58:2420-4
DOI
ScienceOn
|
15 |
Rodriguez-Soriano J. Bartter and related syndromes: the puzzle is almost solved. Pediatr Nephrol 1998;12:315-27
DOI
|
16 |
Han JS, Chang SH, Lee JS. Clinical usefulness of transtubular potassium gradient(TTKG) and urine ammonium in differential diagnosis of hypokalemia. Korean J Nephrol 1997; 16:417-25
|
17 |
Norby L, Flamenbaum W, Lentz R, Ramwell P. Prostaglandins and aspirin therapy in Bartter's syndrome. The Lancet 1976;18:604-6
|
18 |
Ryu JM, Lee JH, Han HW, Park YS. A case of neonatal bartter syndrome. J Korean Soc Pediatr Nephrol 2005;9:255-62
|
19 |
Yoon JH, Kwon JE, Lee JO, Lee SG. A case of Bartter's syndrome. J Korean Pediatr Soc 1993;36:1308-14
|
20 |
Simon DB, Karet FE, Hamdan JM, Dipietro A, Sanjad S, Lifton RP. Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl co-transporter NKCC2. Nat Genet 1996;13:183-8
DOI
ScienceOn
|
21 |
Bowden RE, Gil JR, Radfar N, Taylor AA, Keiser HR. Prostaglandin synthetase inhibitors in Bartter's syndrome. JAMA 1978;239:117-21
DOI
|
22 |
Song JS, Shinn JJ, You KH, Lee HK, Cha WK, Kwon KH, et al. A case of Bartter's syndrome in an adult. Korean J Nephrol 1997;16:567-71
|
23 |
Sieck UV, Ohlsson A. Fetal polyuria and hydramnios associated with Bartter's syndrome. Obstet Gynecol 1984;63: 22S-24S
|
24 |
Cumming WA, Ohlsson A. Nephrocalcinosis in Bartter's syndrome: demonstration by ultrasonography. Pediatr Radiol 1984;14:125-6
DOI
|
25 |
Schlingmann KP, Konrad M, Seyberth HW. Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol 2004;19:13-25
DOI
|
26 |
Cho YS, Yoon YH, Chae BN, Choi CY, Yi KH, Kim YG, et al. Pseudo-Bartter's syndrome with nephrocalcinosis caused by long-term surreptitious furosemide ingestion. Korean J Med 1993;45:255-60
|
27 |
Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Bartter's and Gitelman's Syndromes: from gene to clinic. Nephron Physiol 2004;96:65-78
DOI
ScienceOn
|
28 |
Proesmans W, Devlieger H, Van Assche A, Eqqermont E, Vandenberqhe K, Lemmens F, et al. Bartter's syndrome in two siblings-Antenatal and neonatal observations. Int J Pediatr Nephrol 1985;6:63-70
|
29 |
Rodrigues Pereira R, Hasaart T. Hydramnios and observations in Bartter's syndrome. Acta Obstet Gynecol Scand 1982;61:477-8
DOI
ScienceOn
|
30 |
Fichman MP, Telfer N, Zia P, Speckart P, Golub M, Rude R. Role of prostaglandins in the pathogenesis of Bartter's syndrome. Am J Med 1976;60:785-97
DOI
ScienceOn
|
31 |
Mackie FE, Hodson EM, Roy LP, Knight JF. Neonatal Bartter syndrome-use of indomethacin in the newborn period and prevention of growth failure. Peditr Nephrol 1996;10:756-8
DOI
|
32 |
Mastumoto J, Han BK, Restrepo de Rovetto C, Welch TR. Hypercalciuric Bartter syndrome: resolution of nephrocalcinosis with indomethacin. AJR 1989;152:1251-3
DOI
ScienceOn
|
33 |
Lee HY, Chyung YS, Ahn KJ, Lee SW, Kim MR, Kim YK, et al. A case of Bartter's syndrome in an adult. Korean J Med 1991;40:844-52
|
34 |
Donker AJ, de Jong PE, van Eps LW, Brentjens JR, Barkker K. Doorenbos H. Indomethacin in Bartter's syndrome: dose the syndrome represent a state of hyperprostaglandinism? Nephron 1977;19:200-13
DOI
|
35 |
Kim IS, Kang JH, Shin YH, Lee DK, Kim SN, Pai KS. A case of Bartter syndrome with muscle weakness and short stature. J Korean Soc Pediatr Nephrol 2002;6:259-65
과학기술학회마을
|
36 |
Proesmans W. Bartter syndrome and its neonatal variant. Eur J Pediatr 1997;156:669-79
DOI
|
37 |
Lechacz G, Arbus G, Balfe JW, Wolff ED, Robson L. Effect of ibuprofen on growth in a child with Bartter syndrome. J Pediatr 1979;95:319-20
DOI
|